Atomization device control method and atomization device

Abstract

The application discloses an atomization equipment control method and atomization equipment, and belongs to the technical field of electronic atomization. The atomization equipment control method comprises the following steps: obtaining physical health information of a user; the physical health information comprises blood glucose concentration; determining a health state of the user based on the physical health information; and controlling the atomization equipment to enter different working modes based on the health state of the user. According to the atomization equipment control method provided in the application, linkage between atomization equipment control and user physiological data can be realized, the working state of the atomization equipment is actively managed according to real-time physiological data of the user, and intelligent intervention on the behavior of the user using the atomization equipment is realized.

Description

Technical Field

[0001] This application belongs to the field of electronic atomization technology, and in particular relates to an atomization device control method and an atomization device. Background Technology

[0002] Atomizing devices are devices that convert atomizing matrix into aerosols that can be ingested by users. Some users have specific needs regarding the frequency or dosage of their use.

[0003] In related technologies, users can understand their own health status through health monitoring devices, and then manually control the nebulizer based on their own health status, manually intervening in the frequency or dosage of nebulizer use.

[0004] However, health monitoring devices and nebulizers are independent devices. The former is only responsible for monitoring and displaying the user's physiological data and does not have the ability to intervene in the user's behavior; the latter is manually controlled by the user and lacks a self-control mechanism. Summary of the Invention

[0005] This application provides a method for controlling an atomizing device and an atomizing device, which can actively manage the working status of the atomizing device based on the user's real-time physiological data, and realize intelligent intervention for the user's behavior when using the atomizing device.

[0006] This application provides a method for controlling an atomizing device, the method comprising: Obtain the user's health information; the health information includes blood glucose concentration; Based on the aforementioned health information, the user's current health status is determined; Based on the user's health status, the atomizing device is controlled to enter different working modes.

[0007] In some embodiments, obtaining the user's health information includes: In response to a user's contact with the detection component integrated in the atomizing device, the user's health information is acquired; or, The user's health information is obtained through an external device that is communicatively connected to the atomizing device.

[0008] In some embodiments, determining the user's health status based on the physical health information includes: If the blood glucose concentration is greater than or equal to a first preset concentration threshold and less than or equal to a second preset concentration threshold, the user is determined to be in a normal blood glucose state; the first preset concentration threshold is less than the second preset concentration threshold. If the blood glucose concentration is less than the first preset concentration threshold, or if the blood glucose concentration is greater than the second preset concentration threshold, the user is determined to be in an abnormal blood glucose state.

[0009] In some embodiments, controlling the atomizing device to enter different working modes based on the user's health status includes: When the user's blood sugar is in a normal state, the nebulizer is controlled to enter the normal working mode; When the user is in an abnormal blood glucose state, the nebulizer is controlled to enter a restricted operating mode; in the restricted operating mode, the upper limit of the range of values ​​of the operating parameters of the nebulizer is less than the upper limit of the range of values ​​of the operating parameters of the nebulizer in the normal operating mode.

[0010] In some embodiments, the operating parameters include one or more of the following: the atomization power of the atomizing device, the allowed inhalation frequency of the atomizing device, the allowed number of inhalations of the atomizing device, and the allowed inhalation duration of the atomizing device.

[0011] In some embodiments, determining the user's health status based on the physical health information further includes: If the blood glucose concentration is less than a third preset concentration threshold or greater than a fourth preset concentration threshold, the user is determined to be in a dangerous blood glucose state; the third preset concentration threshold is less than the first preset concentration threshold, and the fourth preset concentration threshold is greater than the second preset concentration threshold. The method of controlling the atomizing device to enter different working modes based on the user's health status also includes: When a user is in a dangerous blood sugar state, the nebulizer is controlled to enter a locked mode; in the locked mode, the nebulizer cannot perform the nebulization function.

[0012] In some embodiments, the method further includes: The interactive components integrated into the atomizing device provide users with interactive information about the atomizing device; the interactive information includes one or more of the following: the current values ​​of the operating parameters of the atomizing device, the current working mode of the atomizing device, the body health information, and the health status.

[0013] In one embodiment, an atomizing device is provided, the atomizing device including an atomizing component and a controller; The atomizing component is used in conjunction with the controller to realize different working modes of the atomizing device; The controller is used to implement the method as described in any of the above embodiments when executing.

[0014] In some embodiments, the atomizing device includes a detection component disposed on the surface of the atomizing device; the detection component is used to acquire the user's physical health information when touched by the user. Alternatively, the atomizing device can be communicatively connected to an external device, which is used to acquire the user's health information.

[0015] In some embodiments, the detection component includes an optical probe and a processing unit; The optical probe is used to emit a first optical signal to the user's contact area when the user touches it, and to receive a second optical signal reflected back from the contact area after emitting the first optical signal. The arithmetic unit is used to determine the user's physical health information based on the second optical signal.

[0016] In some embodiments, the atomizing device further includes an interaction component, which is used to provide the user with interactive information of the atomizing device; the interactive information includes one or more of the following: the current values ​​of the operating parameters of the atomizing device, the current working mode of the atomizing device, the body health information, and the health status; The interactive components include visual interactive components, auditory interactive components, and tactile interactive components; The controller is also used to provide interactive information of the atomizing device to the user through different combinations of the visual interaction component, the auditory interaction component, and the tactile interaction component in different working modes.

[0017] In this embodiment, the nebulizer can acquire real-time health information of the user, including the user's blood glucose concentration; based on the user's health information, the user's health status can be determined; and based on the health status, the nebulizer can be controlled to enter different working modes. By linking health information, health status, and the working modes of the nebulizer, this embodiment provides an intelligent control method for the usage of the nebulizer. It can intelligently manage the working status of the nebulizer based on the user's health information, especially blood glucose concentration, thereby automatically and regularly controlling the user's behavior when using the nebulizer, and realizing intelligent intervention in the user's behavior when using the nebulizer. Attached Figure Description

[0018] To more clearly illustrate the technical solutions of the embodiments of this application, the accompanying drawings used in the embodiments will be briefly introduced below. It should be understood that the following drawings only show some embodiments of this application and should not be regarded as a limitation of the scope. For those skilled in the art, other related drawings can be obtained based on these drawings without creative effort.

[0019] Figure 1 This is a flowchart illustrating the steps of an embodiment of atomizing device control method according to this application; Figure 2 This is a structural block diagram of an atomizing device according to this application; Figure 3 This is a schematic diagram of one method for obtaining physical health information according to this application; Figure 4 This is a diagram illustrating another method of obtaining physical health information in this application. Detailed Implementation

[0020] The technical solutions of the embodiments of this application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this application, not all embodiments. Based on the embodiments of this application, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this application.

[0021] The terms "first," "second," etc., used in the specification and claims of this application are used to distinguish similar objects and not to describe a specific order or sequence. It should be understood that such data can be interchanged where appropriate so that embodiments of this application can be implemented in orders other than those illustrated or described herein, and the objects distinguished by "first," "second," etc., are generally of the same class and are not limited in number; for example, a first object can be one or more. Furthermore, the term "and / or" in the specification and claims is used to describe the relationship between related objects, indicating that three relationships can exist. For example, A and / or B can represent: A alone, A and B simultaneously, and B alone. The character " / " generally indicates that the preceding and following related objects are in an "or" relationship. In the embodiments of this application, the term "multiple" refers to two or more, and other quantifiers are similar.

[0022] The methods provided in this application will be described in detail below with reference to the accompanying drawings, through specific embodiments and application scenarios.

[0023] Reference Figure 1 The diagram illustrates a flowchart of an embodiment of atomizing device control method according to this application. The method includes the following steps: Step 101: Obtain the user's health information; the health information includes blood glucose concentration.

[0024] Atomizing devices are devices that can convert atomizing matrix into aerosols. The function of atomizing devices is to present liquid substances (atomizing matrix) in an aerosol form that is more easily inhaled by the human body or used in specific scenarios. They are widely used in medical, consumer and other fields.

[0025] Users of nebulizers sometimes need to use them regularly or restrictively. For example, if the nebulizer medium contains nicotine, users may need to control the frequency of use or reduce the dosage of the nebulizer medium to decrease nicotine intake. These needs require manual operation, are dependent on the user, and are inherently uncertain and unreliable. Users may forget to perform these operations or operate them inaccurately, making it difficult to achieve the desired results. Regarding health, users can obtain their physiological data through health monitoring devices and then manually control the frequency or dosage of nebulizer use based on this data. This process requires users to correlate physiological data with the nebulizer's operating status, resulting in a less than ideal user experience. In conclusion, current technologies lack solutions that integrate health information, especially blood glucose levels, with the nebulizer's operating status to proactively manage nebulizer use using real-time health information, helping users to control their nebulizer use regularly and scientifically.

[0026] Health information refers to physiological data reflecting a user's physical health status, including but not limited to blood glucose concentration, blood oxygen saturation, pulse, blood pressure, heart rate, lung capacity, and oral temperature. In this embodiment, the focus is on blood glucose concentration; blood glucose concentration refers to the range of glucose levels in the blood. When a user experiences hypoglycemia, they may feel hungry, potentially exacerbating their cravings, making it difficult for them to use the nebulizer regularly and scientifically. By establishing a linkage between blood glucose concentration and the control of the nebulizer, the nebulizer can be controlled based on the acquired blood glucose concentration, ensuring the scientific and safe use of the nebulizer.

[0027] Health information can be obtained through sensors integrated into the nebulizer or through external devices that communicate with the nebulizer; these sensors or external devices can detect and obtain the user's health information in real time or periodically.

[0028] By acquiring health information, especially blood glucose concentration, a data foundation can be laid for the subsequent control of nebulizer devices. Blood glucose concentration serves as an important indicator for quantifying a user's health status, providing a reliable and objective basis for health status assessment. This overcomes the limitation in related technologies where nebulizer devices cannot achieve intelligent control based on physiological data, particularly blood glucose concentration. The system supports multiple data collection methods to adapt to different user needs, balancing convenience and scalability. It can collect various health information for comprehensive analysis or perform precise control based on a single indicator.

[0029] Step 102: Based on the aforementioned health information, determine the user's current health status.

[0030] After obtaining the user's health information, the user's health status can be determined based on the health information. Different health statuses can correspond to different preset control strategies, and different preset control strategies represent different working modes. Thus, a correspondence between health information and the working mode of the nebulizer can be established, realizing the linkage between health information and the working mode of the nebulizer.

[0031] Taking blood glucose concentration as an example, a user's health status can be normal or abnormal (hyperglycemia or hypoglycemia). Abnormal status can be further divided into general abnormal status and severe abnormal status. A user's health status can be determined by setting health thresholds: by using multiple different blood glucose concentration thresholds, blood glucose concentration is divided into multiple intervals. The obtained blood glucose concentration is compared with the preset intervals, and the user's health status is determined based on the comparison results.

[0032] By assessing health status, precise conversion of physiological data into control commands can be achieved. Standardized and quantifiable determination of health status can be achieved through threshold judgments, avoiding subjective misjudgments and enabling subsequent scientific control of the nebulization device. By determining the health status, clear control criteria can be output based on the collected physiological data, establishing a link between physical health information and nebulization working mode. This allows for real-time adaptation to dynamic fluctuations in the user's physical health information, early identification of physical health risks, and targeted treatment, balancing the universal and personalized experience of the nebulization device.

[0033] Step 103: Based on the user's health status, control the atomizing device to enter different working modes.

[0034] This step puts the nebulizer into a working mode that matches the user's current health status and health information. For example, using blood glucose concentration as an example, if the user's health is normal, the nebulizer can operate normally, meaning it's fully usable. If the user's health is abnormal, certain functions of the nebulizer can be restricted (such as reducing nebulization power). Through different working modes, the nebulizer can balance nebulization effectiveness and safety, improving the user experience.

[0035] Based on different health states, the device can be controlled to switch to different working modes, realizing intelligent switching of the device's working modes, avoiding the unreliability of manual operation, lowering the threshold for use, and improving the ease of use of the device.

[0036] Through the above steps, the nebulizer is upgraded from a simple nebulization tool to an intelligent device that can be adapted and controlled according to the user's health status. This avoids the limitations of manually controlled nebulizers, enables intelligent intervention in the user's behavior when using the nebulizer, ensures the expected effect, and improves the automation level and user experience of the nebulizer.

[0037] In summary, in this embodiment, the nebulizer can acquire real-time health information of the user, including the user's blood glucose concentration; based on the user's health information, the user's health status can be determined; and based on the health status, the nebulizer can be controlled to enter different working modes. By linking health information, health status, and the working modes of the nebulizer, this embodiment provides an intelligent control method for the usage of the nebulizer. It can intelligently manage the working status of the nebulizer based on the user's health information, especially blood glucose concentration, thereby automatically and regularly controlling the user's behavior when using the nebulizer, and realizing intelligent intervention in the user's behavior when using the nebulizer.

[0038] In some embodiments, step 101 may include: Sub-step 1011: In response to a user's contact with the detection component integrated in the atomizing device, obtain the user's health information; or, Sub-step 1012: Obtain the user's health information based on an external device that is communicatively connected to the atomizing device.

[0039] Nebulization devices can acquire health information through detection components or external devices; taking blood glucose concentration as an example, as shown in sub-step 1011, the detection component can be a non-invasive blood glucose sensor installed on the nebulization device, which acquires the user's blood glucose concentration through optical signals based on the user's contact operation.

[0040] The detection component can employ non-invasive spectroscopy technology and be positioned on the grip area of ​​the atomizing device. Users only need to cover and touch the sensor area of ​​the detection component with their fingers for a certain period of time to complete the measurement.

[0041] By integrating detection components into the nebulizer, health information is acquired in response to contact operations, eliminating the need for external devices. This simplifies the use of the nebulizer, enhances ease of operation, and allows for rapid acquisition of real-time health information. The short data transmission path ensures timely and accurate health information collection, while the integrated design simplifies the accessories required for the nebulizer, improving its portability and meeting users' needs for quick health information collection anytime, anywhere.

[0042] Taking blood glucose concentration as an example, as shown in sub-step 1012, the nebulizer can also acquire the user's blood glucose concentration through an external device. This external device can be a wearable continuous glucose monitor (CGM), a medical device that tracks blood glucose changes in real time using a subcutaneous sensor. The CGM collects the user's blood glucose concentration and then sends the signal containing the blood glucose concentration to the nebulizer via a communication connection. Upon receiving the signal, the nebulizer demodulates the blood glucose concentration and begins controlling the nebulizer based on the blood glucose concentration. The CGM can maintain a communication connection with the nebulizer via Bluetooth, or it can connect to the user's mobile phone first, and then indirectly connect to the nebulizer via the mobile phone. That is, the blood glucose concentration can be sent directly from the CGM to the nebulizer, or it can be sent to the mobile phone first and then forwarded to the nebulizer by the mobile phone.

[0043] The nebulizer control method provided in this application supports communication between the nebulizer and an external device to obtain health information. It is compatible with mainstream health detection devices on the market, expands the channels for collecting health information, and is suitable for users who already own external detection devices. No additional detection tools are required, reducing user costs. The external device can meet the needs of higher precision and more dimensions of health detection, further improving the comprehensiveness and accuracy of health information collection, without increasing the size and cost of the nebulizer itself, thus balancing device lightweighting and functional expandability.

[0044] This application embodiment achieves flexible acquisition of physical health information through two methods: contact acquisition via detection components and communication acquisition via external devices. It balances convenience and scalability, adapts to different user scenarios and usage habits, and effectively ensures the timeliness, accuracy, and comprehensiveness of health information collection. This lays a solid data foundation for subsequent health status determination and precise control of the nebulization mode, and improves the versatility and feasibility of the nebulization device control method.

[0045] In some embodiments, step 102 may include: Sub-step 1021: If the blood glucose concentration is greater than or equal to a first preset concentration threshold and less than or equal to a second preset concentration threshold, determine that the user is in a normal blood glucose state; the first preset concentration threshold is less than the second preset concentration threshold. Sub-step 1022: If the blood glucose concentration is less than the first preset concentration threshold or the blood glucose concentration is greater than the second preset concentration threshold, determine that the user is in an abnormal blood glucose state.

[0046] In a scheme that uses blood glucose concentration as health information, a user's health status can be determined through multiple preset concentration thresholds. As shown in sub-step 1021, when the blood glucose concentration is between a first preset concentration threshold and a second preset concentration threshold, the user can be determined to be in a normal blood glucose state. The first and second preset concentration thresholds can be set according to normal human blood glucose concentrations. For example, the normal fasting blood glucose concentration is 3.9~6.1 mmol / L, so the first preset concentration threshold can be 3.9 mmol / L and the second preset concentration threshold can be 6.1 mmol / L. Alternatively, the first preset concentration threshold can be set to 4.0 mmol / L and the second preset concentration threshold can be set to 7.3 mmol / L to provide a detection margin for changes in blood glucose concentration, ensuring that the user's health status can be accurately distinguished even when testing after eating.

[0047] The use of dual thresholds to define the range of normal blood glucose levels provides a clear and specific judgment standard. It can accurately define the range of normal blood glucose concentration, provide a reliable basis for determining the corresponding working mode of the nebulizer, ensure the adaptability of the relevant parameters of the nebulizer, and ensure that the nebulizer effect matches the user's physical tolerance, avoiding ineffective or excessive adjustment under normal conditions.

[0048] As shown in sub-step 1022, when the blood glucose concentration is less than the first preset concentration threshold or greater than the second preset concentration threshold, it can be determined that the user is in an abnormal blood glucose state. Specifically, a blood glucose concentration below the first preset concentration threshold indicates that the user's blood glucose concentration is low, possibly due to prolonged fasting or hypoglycemia. A blood glucose concentration above the second preset concentration threshold indicates that the user's blood glucose concentration is high, possibly due to recent eating or hyperglycemia. In these states, the use of the nebulizer should be restricted. Taking the normal blood glucose concentration range for a fasting person as an example, the first preset concentration threshold is 3.9 mmol / L, and the second preset concentration threshold is 6.1 mmol / L. When the user's blood glucose concentration is below 3.9 mmol / L or above 6.1 mmol / L, it can be determined that the user is in an abnormal blood glucose state. Furthermore, when the user's blood glucose concentration is below 3.9 mmol / L, it can be determined that the user is in a suspected hypoglycemic state, and when the user's blood glucose concentration is above 6.1 mmol / L, it can be determined that the user is in a suspected hyperglycemic state.

[0049] By using dual thresholds to delineate abnormal blood glucose states, it is possible to achieve full coverage of abnormal states without omission, promptly trigger the subsequent adaptive working mode of the nebulizer, and avoid the health risks brought about by routine nebulization operations under abnormal states in advance, thus providing a supporting basis for nebulization safety under special health conditions.

[0050] In some embodiments, step 103 may include: Sub-step 1031: When the user's blood sugar is in a normal state, control the nebulizer to enter the normal working mode; Sub-step 1032: When the user is in the abnormal blood glucose state, control the nebulizer to enter the restricted working mode; in the restricted working mode, the upper limit of the value range of the operating parameters of the nebulizer is less than the upper limit of the value range of the operating parameters of the nebulizer in the normal working mode.

[0051] In solutions that use blood glucose concentration as a health indicator, if the user's blood glucose level is normal, the nebulizer can be controlled to enter normal operating mode. In normal operating mode, the nebulizer operates according to its default factory settings, with its operating parameters having a maximum range of values. For example, the nebulizer's atomization power, with a default range of 4-12W, can be selected within this range during normal operation. For instance, if the default configuration is 9W, the nebulizer will operate at 9W during normal operation. Normal operating mode ensures the nebulizer operates with standard parameters, guaranteeing adequate atomization and meeting the user's daily aerosol intake needs.

[0052] In solutions that use blood glucose concentration as a health indicator, if a user is in an abnormal blood glucose state, the nebulizer can be controlled to enter a restricted operating mode. The difference between restricted and normal operating modes is that in restricted mode, the upper limit of the operating parameter range for the nebulizer is smaller than that in normal operating mode. For example, the nebulizer's atomization power, which defaults to 4-12W, can be limited to 4-6W in restricted mode, meaning a maximum power of 6W can be selected. Reducing the upper limit of the atomization power range decreases the maximum amount of aerosol generated per nebulization cycle, thereby reducing the total amount of aerosol ingested by the user.

[0053] When a user is in a state of abnormal blood sugar, the nebulizer can automatically switch to a restricted operating mode. Firstly, this mode can specifically reduce the operating intensity of the nebulizer, avoiding conflicts between the nebulization effect and the user's physical tolerance, effectively preventing discomfort caused by inhaling aerosols when the user is in a state of abnormal blood sugar. Secondly, by restricting operating parameters, differentiated adaptive control can be achieved without manual adjustment, improving the intelligence and ease of operation of the nebulizer. Thirdly, restricting the operating parameters of the nebulizer can adapt to the metabolic characteristics of people with abnormal blood sugar levels, balancing nebulization needs with physical burden, providing users with intelligent intervention capabilities when using the nebulizer, and improving the safety of use for special populations.

[0054] In some embodiments, the operating parameters include one or more of the following: the atomization power of the atomizing device, the allowed inhalation frequency of the atomizing device, the allowed number of inhalations of the atomizing device, and the allowed inhalation duration of the atomizing device.

[0055] Operating parameters include, but are not limited to, the atomization power of the atomizing device, the allowable inhalation frequency of the atomizing device, the allowable number of inhalations of the atomizing device, and the allowable inhalation duration of the atomizing device.

[0056] When an atomizing device performs an atomization operation, the power allocated to the atomizing component is used to convert the atomizing matrix into an aerosol through thermal effects. In a restricted operating mode, the upper limit of the atomizing power range of the atomizing device is reduced, specifically by lowering the maximum selectable value of the atomizing power. By reducing the maximum selectable value of the atomizing power, the efficiency of the atomizing device in converting the atomizing matrix into an aerosol can be reduced, thereby reducing the amount of aerosol inhaled by the user.

[0057] The permissible aspiration frequency of an atomizing device refers to the number of aspirations allowed per unit time. In restricted operating mode, the upper limit of the permissible aspiration frequency is reduced; specifically, the permissible aspiration frequency can be lowered, meaning the number of aspirations allowed per unit time during operation is reduced. The permissible aspiration frequency can be adjusted by setting a cooling period between adjacent aspiration actions. During the cooling period, the atomizing device does not perform atomization operations. By increasing the duration of the cooling period, the atomization operations can be forced to pause for a certain period, thereby reducing the aerosol production per unit time.

[0058] The allowed number of inhalations for a nebulizer refers to the maximum number of puffs permitted for a single user. In restricted operating mode, this maximum allowed number of inhalations is reduced, meaning the total number of puffs that can be used is decreased. Once the allowed number of inhalations is exhausted, the nebulizer will be locked and unable to perform nebulization. By reducing the allowed number of inhalations, user behavior can be effectively controlled, ensuring that the aerosol inhaled by the user remains within a preset range.

[0059] The permissible inhalation time of an atomizing device refers to the duration of a single inhalation action allowed by the atomizing device. In restricted operating mode, the upper limit of the permissible inhalation time of the atomizing device is reduced, which means that the maximum allowed duration of a single inhalation action is reduced. By reducing the maximum selectable value of the permissible inhalation time, the amount of aerosol inhaled by the user can be reduced.

[0060] Operating parameters such as atomization power, permissible inhalation frequency, permissible number of inhalations, and permissible inhalation duration make the linkage control between health status and working mode more practical. The normal working mode can ensure the efficiency of the atomization equipment, while the restricted working mode can achieve safe adaptation by reducing the working parameters, realizing multi-dimensional precise control, taking into account the stability of equipment operation, safety of use, and adaptability, and further improving the feasibility of atomization equipment control methods.

[0061] In some embodiments, step 102 may further include: Sub-step 1023: If the blood glucose concentration is less than a third preset concentration threshold or greater than a fourth preset concentration threshold, determine that the user is in a dangerous state of blood glucose; the third preset concentration threshold is less than the first preset concentration threshold, and the fourth preset concentration threshold is greater than the second preset concentration threshold. Step 103 may also include: Sub-step 1033: When the user is in the dangerous blood sugar state, control the nebulizer to enter the lock mode; in the lock mode, the nebulizer cannot perform the nebulization function.

[0062] Furthermore, blood glucose concentration can be further categorized using a third and a fourth preset concentration threshold, enabling more detailed and targeted control. When the third preset concentration threshold is lower than the first preset threshold, and the user's blood glucose concentration falls between these thresholds, it indicates that the user has not eaten for a long time or is experiencing mild hypoglycemia. In this case, the nebulizer can be controlled to enter a restricted operating mode. When the user's blood glucose concentration falls below the third preset threshold, it indicates that the user is in a dangerous state, indicating severe hypoglycemia, and the nebulizer can be controlled to enter a locked mode. Similarly, when the fourth preset concentration threshold is higher than the second preset threshold, and the user's blood glucose concentration falls between these thresholds, it indicates that the user has just eaten or is experiencing mild hyperglycemia. In this case, the nebulizer can be controlled to enter a restricted operating mode. When the user's blood glucose concentration falls above the fourth preset threshold, it indicates that the user is in a dangerous state, indicating severe hyperglycemia, and the nebulizer can be controlled to enter a locked mode. Taking the normal range of blood glucose concentration in the human body during fasting as an example, the first preset concentration threshold is 3.9 mmol / L, the second preset concentration threshold is 6.1 mmol / L, then the third preset concentration threshold can be 2.8 mmol / L, and the fourth preset concentration threshold can be 7.8 mmol / L.

[0063] As shown in sub-step 1033, when the user is in a dangerous blood sugar state, the nebulizer enters a locked mode. In locked mode, the nebulizer cannot perform nebulization and cannot generate aerosols, preventing the user from continuing to ingest them. For scenarios with extremely dangerous blood sugar concentrations, the locked mode can prevent nebulization from the source, completely avoiding serious health risks such as dizziness and shock caused by nebulization stimulation due to extremely poor physical tolerance in dangerous states, maximizing the protection of the user's life and health safety. The tiered mode control (normal working mode - restricted working mode - locked mode) is precisely matched with the three levels of health status (normal blood sugar state - abnormal blood sugar state - dangerous blood sugar state), adapting to the differentiated protection needs of different risk levels and improving the scientific nature and adaptability of the control method. The locked mode can automatically lock the nebulizer without manual intervention, preventing the user from accidentally starting the nebulization operation, and at the same time, it can remind the user to prioritize dealing with dangerous blood sugar states, taking into account both safety protection and health warning functions.

[0064] By adding a blood glucose danger state judgment and corresponding locking mode, the system achieves a precise three-level classification of health status from normal, abnormal to dangerous, and correspondingly, a tiered protection system for the nebulizer device from normal operation, parameter limitation to function lock. This not only fills the protection blind spot of only distinguishing between normal and abnormal states, but also provides a risk mitigation measure through function lock in blood glucose danger states, greatly improving the safety and compatibility of the nebulizer device.

[0065] In some embodiments, the atomizing device control method may further include: Step 104: Provide the user with interactive information about the atomizing device through the interactive components integrated in the atomizing device; the interactive information includes one or more of the following: the current values ​​of the operating parameters of the atomizing device, the current working mode of the atomizing device, the body health information, and the health status.

[0066] This method also supports providing users with feedback on the current status of the nebulizer and their physical condition through interactive components. These interactive components provide users with interactive information through visual, auditory, and tactile means; the interactive information may include one or more of the current values ​​of the nebulizer's operating parameters, the nebulizer's current operating mode, and physical health information and status.

[0067] The current values ​​of the parameters of the atomizing device can be the current atomization power, the current allowed number of puffs and the remaining number of puffs, the current allowed puffing frequency, the cooling period between adjacent atomization operations, etc.

[0068] The operating modes of a nebulizer can include normal operating mode, restricted operating mode, and lock mode. The corresponding interactive information in these modes can be reminders to the user. For example, in lock mode, the indicator light can turn red to indicate that the nebulizer has entered lock mode, and the user can be informed of blood glucose concentration issues through a speaker or display screen.

[0069] By providing health information and health status, the system can synchronize detected physiological data and health status in real time without requiring users to query the data. This allows users to keep track of fluctuations in their health information and provides immediate warnings for abnormal or dangerous conditions, reminding users to address their health issues first, thus meeting the dual needs of nebulization protection and health management.

[0070] Interactive components can specifically be devices such as displays, speakers, indicator lights, and vibration motors. Interactive components can provide interactive information only once or repeatedly to the user. For example, in locked mode, the indicator light of the nebulizer turns red and flashes continuously, while the speaker of the nebulizer repeatedly broadcasts the prompt "Blood sugar dangerous, device locked, please control blood sugar and monitor blood sugar in time."

[0071] By integrating interactive components into the nebulizer device to push interactive information, the system enables visualized, perceptible, and transparent feedback of information related to both the nebulizer device and the user. This allows users to monitor their health status and the working status of the nebulizer device in real time, enhancing the intelligence and interactive experience of the nebulizer device control method. It also serves as a health warning and operation prompt, further ensuring safety and convenience in use.

[0072] In summary, in this embodiment, the nebulizer can acquire real-time health information of the user, including the user's blood glucose concentration; based on the user's health information, the user's health status can be determined; and based on the health status, the nebulizer can be controlled to enter different working modes. By linking health information, health status, and the working modes of the nebulizer, this embodiment provides an intelligent control method for the usage of the nebulizer. It can intelligently manage the working status of the nebulizer based on the user's health information, especially blood glucose concentration, thereby automatically and regularly controlling the user's behavior when using the nebulizer, and realizing intelligent intervention in the user's behavior when using the nebulizer.

[0073] This application also provides an atomizing device 200, see reference. Figure 2 The atomizing device 200 includes an atomizing component 201 and a controller 202; the atomizing component 201 is used to cooperate with the controller 202 to realize different working modes of the atomizing device 200; the controller 202 is used to implement the method as described in any of the above embodiments.

[0074] The main function of the atomizing component is to realize the atomization operation, that is, to convert the atomizing matrix into an aerosol. While the controller 202 executes the atomizing device control method, the atomizing component responds to the instructions issued by the controller to realize different working modes of the atomizing device.

[0075] As for the embodiment of controller 202, since it is basically similar to the method embodiment, the relevant parts can be referred to in the description of the method embodiment.

[0076] In some embodiments, refer to Figure 3 , Figure 3 This application provides a method for obtaining physical health information; the atomizing device includes a detection component 203 disposed on the surface of the atomizing device; the detection component 203 is used to obtain the user's physical health information when touched by the user; or, refer to Figure 4 , Figure 4 Another method for obtaining physical health information is provided in this application embodiment; the atomizing device 200 is communicatively connected to the external device 300, and the external device 300 is used to obtain the user's physical health information.

[0077] The nebulizer integrates detection components to respond to user touch operations and acquire health information without relying on external devices. This simplifies the usage process, improves ease of operation, and allows for rapid acquisition of real-time health information. The short data transmission path ensures timely and accurate health information collection, while the integrated design simplifies the accessories required for the nebulizer, enhancing its portability and meeting users' needs for quick health information collection anytime, anywhere.

[0078] like Figure 4 As shown, the external device 300 can communicate directly with the nebulizer 200, or it can communicate indirectly with the nebulizer 200 through devices such as a mobile phone 400. That is, health information can be sent directly from the external device 300 to the nebulizer 200, or it can be sent to the mobile phone 400 first, and then forwarded to the nebulizer 200 from the mobile phone 400.

[0079] The nebulizer provided in this application supports communication with external devices to obtain health information, thus being compatible with mainstream health testing devices on the market, expanding the channels for health information collection, and adapting to users who already own external testing devices without the need for additional testing tools, reducing user costs. External devices can meet the needs for higher precision and more multi-dimensional health testing, further improving the comprehensiveness and accuracy of health information collection, while not increasing the size and cost of the nebulizer itself, balancing device lightweighting and functional expandability.

[0080] In some embodiments, the detection component includes an optical probe and a processor; the optical probe is used to emit a first optical signal to the user's contact area when touched by the user, and to receive a second optical signal reflected back from the contact area after emitting the first optical signal; the processor is used to determine the user's physical health information based on the second optical signal.

[0081] The detection component can be an optical blood glucose sensor, whose main components include an optical probe and a processor. The optical probe can generate and capture optical signals, while the processor can determine specific health information based on these optical signals.

[0082] Taking blood glucose concentration as an example, the detection component can be integrated into the grip of the nebulizer. Specifically, the user's blood glucose concentration can be determined by spectral absorption or Raman spectroscopy. Spectral absorption is based on the absorption characteristics of glucose to near-infrared light of a specific wavelength to measure blood glucose concentration. Therefore, the first optical signal can be a near-infrared light signal (wavelength 760 nm-940 nm), and the second optical signal is a reflected light signal. Blood glucose concentration is determined by spectral analysis of the reflected light signal. Raman spectroscopy is based on the Raman scattering of glucose to determine blood glucose concentration. Therefore, the first optical signal can be a visible light signal, and the second optical signal can be a scattered light signal reflected back to the optical probe. Blood glucose concentration can be determined by analyzing the frequency changes of the scattered light.

[0083] The optical probe fits snugly against the grip contact area (detection area) on the holding end, facilitating user contact and coverage. Utilizing an integrated detection architecture combining the optical probe and a processor, health information can be obtained without invasive blood sampling, enabling non-invasive blood glucose testing. This significantly improves user comfort and acceptance, avoiding the infection risks and pain associated with blood collection. The integrated component design is compatible with the nebulizer itself, eliminating the need for external consumables, reducing usage costs and operational barriers, and enhancing testing convenience and device integration.

[0084] In some embodiments, the atomizing device further includes an interaction component, which is used to provide the user with interactive information of the atomizing device; the interactive information includes one or more of the following: the current value of the operating parameters of the atomizing device, the current working mode of the atomizing device, physical health information, and health status; the interaction component includes a visual interaction component, an auditory interaction component, and a tactile interaction component; the controller is also used to provide the user with interactive information of the atomizing device through different combinations of the visual interaction component, the auditory interaction component, and the tactile interaction component in different working modes.

[0085] Visual interaction components may include indicator lights and displays; auditory interaction components may include speakers and buzzers; and tactile interaction components may include vibration motors.

[0086] Taking blood glucose concentration as an example, when the nebulizer enters different working modes, the interactive components can provide different combinations to provide interactive information.

[0087] For example, when the nebulizer enters normal operating mode, it provides a basic set of interactions; the display screen in the visual interaction component shows text such as "Current blood glucose concentration 4.6 mmol / L", "Blood glucose concentration normal", and "Current nebulization power: 10W", and the indicator light in the visual interaction component is set to solid green; the speaker in the auditory interaction component broadcasts the voice message "Blood glucose normal" once and then stops speaking; the vibration motor in the tactile interaction component is not triggered.

[0088] When the nebulizer enters restricted operating mode, it provides a combination of interactive elements with subtle warnings. For example, the display screen highlights text such as "Current blood glucose concentration 7.3 mmol / L", "Blood glucose abnormal", and "Current nebulizer power 6W", while the indicator light turns yellow and flashes slowly (e.g., once per second); the speaker broadcasts a message once: "Blood glucose abnormal, the device has switched to restricted operating mode, please monitor your blood glucose"; the buzzer sounds twice; and the vibration motor vibrates twice with low amplitude (half a second each time).

[0089] When the nebulizer enters locked mode, it provides a combination of highly alert interactive elements. For example, the display screen will highlight and flash text messages such as "Current blood glucose 8.6 mmol / L", "Nebulizer component locked", and "Please seek medical attention to control blood sugar immediately", while the indicator light turns red and flashes rapidly (e.g., 3 times per second); the speaker will repeat the voice message "Warning, blood sugar dangerous, device locked, please seek medical attention to control blood sugar immediately" twice, the buzzer will sound three times (each lasting 1 second); and the vibration motor will vibrate three times with high amplitude (each lasting 2 seconds).

[0090] Understandably, when the user is visually impaired, the tactile and audio interaction components can be enhanced, for example, by increasing the number of voice prompts or the vibration frequency of the vibration motor, to ensure that the user can obtain interactive information; similarly, when the user is hearing impaired, the tactile and visual interaction components can be enhanced.

[0091] Interactive components integrate visual, auditory, and tactile interaction modes to break through the limitations of single interaction methods, achieve multimodal interaction coverage, adapt to the interaction habits and needs of different user groups (such as the elderly, visually / hearing impaired users, and ordinary users), improve the reach of interactive information, avoid users missing key information due to the failure of a single interaction, and ensure the comprehensiveness and reliability of interactive feedback.

[0092] The interactive component combinations are configured differently according to working modes to achieve precise linkage between interactive information and scene adaptation, making interactive feedback more targeted, avoiding irrelevant information redundancy, and improving information transmission efficiency. The combination of multiple interactive components can realize multiple reminders of information, strengthen the warning effect of key information (such as abnormal / dangerous blood sugar status, mode switching), reduce the probability of users ignoring risk warnings, and further improve the safety of nebulizers. Differentiated combinations are suitable for different usage scenarios (quiet / noisy, bright / dark light environments), improve the scene adaptability of interaction and user experience, and take into account convenience and practicality.

[0093] The following two usage scenarios briefly illustrate the usage process of the atomizing device provided in this application embodiment; In one application scenario, the nebulizer obtains blood glucose concentration through a detection component; First, the user picks up the atomizing device and naturally covers the detection area of ​​the detection component with their finger; The detection component completes the detection after a few seconds, obtaining a blood glucose concentration of 5.5 mmol / L, and sends it to the controller of the nebulizer. The controller determines that 5.5 mmol / L falls within the normal blood glucose concentration range, confirms that the user's blood glucose level is normal, and enters normal working mode; The controller sends a "full power operation" command to the atomizing components and other related components, and sends a "normal status" message to the display screen of the atomizing device; Once the user sees "Blood sugar 5.5, Status: Normal" displayed on the screen, they can use the nebulizer normally.

[0094] In another use case, the user wears an external CGM, which communicates indirectly with the atomizing device via a mobile phone; CGM detected that the user's blood glucose concentration dropped to 3.6 mmol / L and sent this data to the controller of the nebulizer via the mobile phone; The controller determines that 3.6 mmol / L falls within the low blood glucose concentration range, identifies the user as being in an abnormal blood glucose state, and triggers the restricted working mode. The controller limits the atomization power to 50% of the normal operating mode and sets a maximum of one puff per minute; The nebulizer vibrates once, and the display shows "Blood sugar is low, usage is limited, please replenish energy".

[0095] Once the CGM and controller detect that the user's blood glucose level has returned to normal, the restricted working mode is lifted, and the system returns to normal working mode.

[0096] In summary, in this embodiment, the nebulizer can acquire real-time health information of the user, including the user's blood glucose concentration; based on the user's health information, the user's health status can be determined; and based on the health status, the nebulizer can be controlled to enter different working modes. By linking health information, health status, and the working modes of the nebulizer, this embodiment provides an intelligent control method for the usage of the nebulizer. It can intelligently manage the working status of the nebulizer based on the user's health information, especially blood glucose concentration, thereby automatically and regularly controlling the user's behavior when using the nebulizer, and realizing intelligent intervention in the user's behavior when using the nebulizer.

[0097] It should be noted that all information and data obtained in the embodiments of the present invention were obtained with the authorization of the information / data holder.

[0098] Numerous specific details are set forth in the specification provided herein. However, it will be understood that embodiments of the invention may be practiced without these specific details. In some instances, well-known methods, structures, and techniques have not been shown in detail so as not to obscure the understanding of this specification.

[0099] Similarly, it should be understood that, in order to simplify the invention and aid in understanding one or more of the various inventive aspects, in the above description of exemplary embodiments of the invention, various features of the invention are sometimes grouped together in a single embodiment, figure, or description thereof. However, this disclosure should not be construed as reflecting an intention that the claimed invention requires more features than are expressly recited in each claim. Rather, as reflected in the following claims, inventive aspects lie in fewer than all features of a single foregoing disclosed embodiment. Therefore, the claims following the detailed description are hereby expressly incorporated into this detailed description, wherein each claim itself is a separate embodiment of the invention.

[0100] Those skilled in the art will understand that modules in the device of the embodiments can be adaptively changed and placed in one or more devices different from that embodiment. Modules, units, or components in the embodiments can be combined into a single module, unit, or component, and further, they can be divided into multiple sub-modules, sub-units, or sub-components. Except where at least some of such features and / or processes or units are mutually exclusive, any combination can be used to combine all features disclosed in this specification (including the accompanying claims, abstract, and drawings) and all processes or units of any method or device so disclosed. Unless expressly stated otherwise, each feature disclosed in this specification (including the accompanying claims, abstract, and drawings) may be replaced by an alternative feature that serves the same, equivalent, or similar purpose.

[0101] It should be noted that the above embodiments are illustrative of the invention and not restrictive, and that those skilled in the art can devise alternative embodiments without departing from the scope of the appended claims. In the claims, any reference signs placed between parentheses should not be construed as limiting the claims. The word "comprising" does not exclude the presence of elements or steps not listed in the claims. The word "a" or "an" preceding an element does not exclude the presence of a plurality of such elements. The invention can be implemented by means of hardware comprising several different elements and by means of a suitably programmed computer. In the unit claims enumerating several means, several of these means may be embodied by the same item of hardware. The use of the words first, second, and third, etc., does not indicate any order. These words can be interpreted as names.

[0102] The above are merely specific embodiments of the present invention, but the scope of protection of the present invention is not limited thereto. Any variations or substitutions that can be easily conceived by those skilled in the art within the technical scope disclosed in the present invention should be included within the scope of protection of the present invention. Therefore, the scope of protection of the present invention should be determined by the scope of the claims.

Claims

1. A control method for an atomizing device, characterized in that, The method includes: Obtain the user's health information; the health information includes blood glucose concentration; Based on the aforementioned health information, the user's current health status is determined; Based on the user's health status, the atomizing device is controlled to enter different working modes.

2. The method according to claim 1, characterized in that, The acquisition of the user's health information includes: In response to a user's contact with the detection component integrated in the atomizing device, the user's health information is acquired; or, The user's health information is obtained through an external device that is communicatively connected to the atomizing device.

3. The method according to claim 1, characterized in that, Determining the user's health status based on the aforementioned health information includes: If the blood glucose concentration is greater than or equal to a first preset concentration threshold and less than or equal to a second preset concentration threshold, the user is determined to be in a normal blood glucose state; the first preset concentration threshold is less than the second preset concentration threshold. If the blood glucose concentration is less than the first preset concentration threshold, or if the blood glucose concentration is greater than the second preset concentration threshold, the user is determined to be in an abnormal blood glucose state.

4. The method according to claim 3, characterized in that, The method of controlling the atomizing device to enter different working modes based on the user's health status includes: When the user's blood sugar is in a normal state, the nebulizer is controlled to enter the normal working mode; When the user is in an abnormal blood glucose state, the nebulizer is controlled to enter a restricted operating mode; in the restricted operating mode, the upper limit of the range of values ​​of the operating parameters of the nebulizer is less than the upper limit of the range of values ​​of the operating parameters of the nebulizer in the normal operating mode.

5. The method according to claim 4, characterized in that, The operating parameters include one or more of the following: the atomization power of the atomizing device, the allowable inhalation frequency of the atomizing device, the allowable number of inhalations of the atomizing device, and the allowable inhalation duration of the atomizing device.

6. The method according to claim 3, characterized in that, The method of determining the user's health status based on the physical health information also includes: If the blood glucose concentration is less than a third preset concentration threshold or greater than a fourth preset concentration threshold, the user is determined to be in a dangerous blood glucose state; the third preset concentration threshold is less than the first preset concentration threshold, and the fourth preset concentration threshold is greater than the second preset concentration threshold. The method of controlling the atomizing device to enter different working modes based on the user's health status also includes: When a user is in a dangerous blood sugar state, the nebulizer is controlled to enter a locked mode; in the locked mode, the nebulizer cannot perform the nebulization function.

7. The method according to claim 1, characterized in that, The method further includes: The interactive components integrated into the atomizing device provide users with interactive information about the atomizing device; the interactive information includes one or more of the following: the current values ​​of the operating parameters of the atomizing device, the current working mode of the atomizing device, the body health information, and the health status.

8. An atomizing device, characterized in that, The atomizing device includes an atomizing component and a controller; The atomizing component is used in conjunction with the controller to realize different working modes of the atomizing device; The controller is used to implement the method as described in any one of claims 1-7 when executed.

9. The atomizing device according to claim 8, characterized in that, The atomizing device includes a detection component disposed on the surface of the atomizing device; the detection component is used to acquire the user's physical health information when touched by the user. Alternatively, the atomizing device can be communicatively connected to an external device, which is used to acquire the user's health information.

10. The atomizing device according to claim 9, characterized in that, The detection component includes an optical probe and a computing unit; The optical probe is used to emit a first optical signal to the user's contact area when the user touches it, and to receive a second optical signal reflected back from the contact area after emitting the first optical signal. The arithmetic unit is used to determine the user's physical health information based on the second optical signal.

11. The atomizing device according to claim 8, characterized in that, The atomizing device also includes an interactive component, which is used to provide the user with interactive information about the atomizing device; the interactive information includes one or more of the following: the current values ​​of the operating parameters of the atomizing device, the current working mode of the atomizing device, the body health information, and the health status. The interactive components include visual interactive components, auditory interactive components, and tactile interactive components; The controller is also used to provide interactive information of the atomizing device to the user through different combinations of the visual interaction component, the auditory interaction component, and the tactile interaction component in different working modes.

Images